We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Valirx Plc | LSE:VAL | London | Ordinary Share | GB00BLH13C52 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.45 | 3.40 | 3.50 | 3.45 | 3.45 | 3.45 | 0.00 | 07:40:09 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 0 | -2.37M | -0.0262 | -1.32 | 3.11M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/9/2021 12:36 | It's good to see this is rising not on a load of PI's buying but clearly larger buys being filled in the background, who will be buying based on a longer term outlook | dope007 | |
16/9/2021 11:59 | ht t ps://t.me/joinchat/Q Telegram group with most of the TR1 holders No spaces | ultimatejustice9 | |
16/9/2021 11:55 | I'm 35p down on my initial investment.....once I am 35p up I will sell | averagejoe3 | |
16/9/2021 11:29 | Leak on 201 news ? | 412069 | |
16/9/2021 11:19 | Shareholder base changing which is good news looking at the trading since Cenkos appeared | dope007 | |
16/9/2021 11:14 | From over on the lse BB Deal worked in 650,000 @ 24.5 Good Luck Guys...... | 412069 | |
16/9/2021 11:01 | I note Cenkos tweeted it immediately | dope007 | |
16/9/2021 10:33 | Interesting | carlisle44 | |
16/9/2021 10:21 | Maybe the market does like it. | 412069 | |
16/9/2021 07:30 | Try every Avenue, till we get there ! | amaretto1 | |
16/9/2021 07:29 | Mmmmm you wouldn't sub let a product if a large deal was in the cards regarding the breast cancer peptide....We will see, it's another string ! | amaretto1 | |
16/9/2021 07:18 | RNS ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women's health, has entered an Evaluation Agreement with a leading London university to investigate a novel technology designed to treat breast cancer. Under the agreement, the Company will carry out a defined series of preclinical tests on the drug candidate molecule over the next nine months to validate the technology and determine suitability for commercialisation. This preclinical evaluation, the cost of which will be borne by ValiRx up to £75,000, will investigate the action of the molecule against Triple Negative Breast Cancer and other indications. At the conclusion of the evaluation period the Company has an option to license the technology on pre-agreed terms. | uknighted | |
15/9/2021 18:44 | Can’t recall saying was out of here . If the truth bothers and irritates so be it . If honesty is negativity , then truth is loss. Ps sorry if I offended. | gpferg | |
15/9/2021 16:36 | Gpferg - I thought you were 'out of here' a few weeks back? Why do you keep returning with your negative posts? | djj2014 | |
15/9/2021 15:58 | The only reason for people to stay invested here is, an exercise in loss cutting . To get back what they have invested and lost . This really is like flogging a dead horse. That would be the optimistic view. | gpferg | |
15/9/2021 15:57 | The only reason for people to stay invested here is, an exercise in loss cutting . To get back what they have invested and lost . This really is like flogging a dead horse. That would be the optimistic view. | gpferg | |
14/9/2021 16:10 | Lol, a good old fashioned "Tree Shake" by market makers at The Orchard Funding(ORCH) today, a small volume of sales, I think some 11k in five trades at circa 57p/58p and the dealing spread has gone from 57p/60p yesterday to 52p bid, 60p offered. The mid price is now showing as 56p -2.5p regards | rainmaker | |
14/9/2021 16:10 | Sorry I had a duplicate post so let me use this as an opportunity to tell you a little about Orchard Funding (ORCH) they raise money to lend to Customers with large "one off " payment commitment say Car insurance through their Bexhill subsidiary or professional fee funding and a large lump sum due in one payment is spread over as much as 10 months in far more affordable instalments. Although they were the unwitting victims of a fraud a while back, they have never had a Customer default on a payment. They are currently a Ben Graham bargain with liquid assets less all liabilities of 72p so at the current offer price of 60p their bargain ratio is 1.2 Although they have been list/quoted business for a relatively short period, the CEO who owns the majority of the shares has been successfully involved in the professional fee funding business for 20+ years so there's very much a tried and tested proven business model and there is understandably a necessity and strong demand for their services. The Company withdrew its application with the Bank Of England for a banking license due to the Covid-19 pandemic but this may well be put back on the agenda in the near future since we seem to have returned to some semblance of normality. Furthermore the Company has developed its own software for making lending decisions and there may well be hidden value in the commercialisation of this product. Orchard Funding have been exploring new avenues of potentially more lucrative new markets and we await news on this. Company pays a 3p division so current historic yield is 5% and trades at 9.28 times earnings. AIMHO, DYOR as I have done mine regards | rainmaker | |
14/9/2021 14:22 | HDT if interested read the thread. Look at the lighting solution hardware they offer, growth , and margin. Market cap £3.9M Cash nett £2.6M Real cost to buy 100% of the company at today’s price £1.3M. In profit. | sunshine today | |
14/9/2021 14:03 | Ref French Connection(FCCN), 22p, +1.50p "This is an excruciating long wait since the last update."Boonkoh,if you're not already familiar with it, welcome to wonderful world of Stockmarket Value Investing and all those personal qualities eg patience,discipline etc that your Primary School told you were important but you didn't understand why at the time but you do now! I calculate French Connection's intrinsic value to be substantially above current prices and IMHO we therefore have a huge margin of safety acting as a buffer or cushion to protect us. If you read the annual reports, you'll realise that the average retail shop lease has very little time left to run and that as leases expire, French Connection are ruthlessly negotiating sharply lower rents and more flexible terms or simply handing back the lease. Of course in the current, very testing high street retail climates with plenty of unoccupied retail outlets, the Landlords are only too willing to oblige. So I believe the days of massive loss making retail outlet division for French Connection are long gone. The other two divisions, the wholesale business which is particularly strong in North America and the licensing business are both excellent businesses. FC also have some £26mln of tax losses to utilise so forgetting the prospective bidders for a moment, if we have news of more favourable trading- which IMHO we should get and a retail division near break even then IMHO the share price can easily double from current levels. AIMHO, DYOR as I have done mine. regards and best wishes | rainmaker | |
14/9/2021 08:32 | I’m certain of that so before 28th and sooner because we need time to get the questions in. | 412069 | |
13/9/2021 17:53 | Suzy, will come good !I have been in VAL for many years and have full trust in Suzy!I think we should have news before the Q&A | jayj4u | |
13/9/2021 11:27 | I wish people would stop pumping this. The same old false optimism from the usual suspects . If this was any good we would all have reaped the benefits . Most people with an ounce of sense now they are being hoodwinked.Alas though as the saying goes a nudge as good as a wink. I’m not going to go on about wasting your time and money , I will leave it to your imagination , It as served you well especially if you are invested here. | gpferg | |
10/9/2021 16:41 | No ... 433 shares ... lolI'm joking | amaretto1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions